Samuel J Haryono

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Asian Pacific journal of cancer prevention : APJCP

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rizky Ifandriani Putri, Samuel J Haryono, Bayu Brahma, Yuniar Harris Prayitno, Noorwati Sutandyo
Prognostic Values of CD8+, PARP, and EGFR on Overall Survival in Patients with Triple-Negative Breast Cancer. Asian Pacific journal of cancer prevention : APJCP 25 (3) (2024)
Rizky Ifandriani Putri, Samuel J Haryono, Bayu Brahma, Yuniar Harris Prayitno, Noorwati Sutandyo
Prognostic Values of CD8+, PARP, and EGFR on Overall Survival in Patients with Triple-Negative Breast Cancer. Asian Pacific journal of cancer prevention : APJCP 25 (3) (2024)
Rizky Ifandriani Putri, Samuel J Haryono, Bayu Brahma, Yuniar Harris Prayitno, Noorwati Sutandyo
Prognostic Values of CD8+, PARP, and EGFR on Overall Survival in Patients with Triple-Negative Breast Cancer. Asian Pacific journal of cancer prevention : APJCP 25 (3) (2024)
Baitha Palanggatan Maggadani, null Harmita, Samuel J Haryono, Marcellino Ryan Rinaldi, Yahdiana Harahap
Volumetric Absorptive Microsampling as a New Biosampling Tool for Monitoring of Tamoxifen, Endoxifen, 4-OH Tamoxifen and N-Desmethyltamoxifen in Breast Cancer Patients. Drug design, development and therapy 15 (2021)